But results from a Korean study of cholangiocarcinoma patients after surgery suggest: The expression rate of HER2 protein appears to be lower in extrahepatic cholangiocarcinoma compared to the results of studies in intrahepatic cholangiocarcinoma. Here, ERBB2 is linked to cholangiocarcinoma.